Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05576610
Other study ID # HUSMalaysia
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 31, 2023
Est. completion date January 1, 2024

Study information

Verified date September 2023
Source Hospital Universiti Sains Malaysia
Contact Dr Ashwini M Madawana, BDS
Phone +60126866033
Email drashwini.m@student.usm.my
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

An interventional study will be done on evaluating the Effect of Enzyme-containing Mouth Spray on Oral Health Status and S.Mutans levels in Paediatric Patients attending Hospital Universiti Sains Malaysia ( HUSM ) , Kelantan. This study will be comparing the gingivitis score , plaque score and saliva bacteria count between the patients receiving a standard preventive advice alongside with normal saline mouth spray and those receiving standard preventive advice alongside with an enzyme containing mouth spray .


Description:

General Objective To evaluate the effect of enzyme-containing mouth sprays on children's oral health compared to those receiving normal saline mouth spray with standard preventive advice after a 4-week follow-up. Specific Objectives 1. To compare the mean plaque score in children using enzyme-containing mouth sprays with standard preventive advice compared to children receiving normal saline mouth spray with standard preventive advice after a 4-week follow-up. 2. To compare the mean gingivitis score in children using enzyme-containing mouth sprays with standard preventive advice compared to children receiving normal saline mouth spray with standard preventive advice after a 4-week follow-up. 3. To compare the mean saliva bacterial count in children using enzyme-containing mouth sprays with standard preventive advice compared to children receiving receiving normal saline mouth spray with standard preventive advice after a 4-week follow-up.


Recruitment information / eligibility

Status Recruiting
Enrollment 84
Est. completion date January 1, 2024
Est. primary completion date December 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 4 Years to 7 Years
Eligibility Inclusion Criteria: - Children of age group 4-7 Exclusion Criteria: - Children with medical problems - Children with Special Needs - Uncooperative Children ( Level of Cooperation would be measured using Frankl's behavior scale) Reviewer's comment : To list down Frankl's Classification and how we define uncooperative As per AAPD 2022 , The Frankl behavior rating scale is a frequently used behavior rating systems in both clinical dentistry and research. This scale indicates observed child's behaviors into four categories (1; Definitely negative, 2; Negative, 3; Positive, 4; Definitely positive) 1. _ _ Definitely negative. Refusal of treatment, forceful crying, fearfulness, or any other overt evidence of extreme negativism. 2. _ Negative. Reluctance to accept treatment, uncooperative, some evidence of negative attitude but not pronounced (sullen, withdrawn). 3. + Positive. Acceptance of treatmen, cautious behavior at times, willingness to comply with the dentist, at times with reservation, but patient follows the dentist's directions cooperatively. 4. ++ Definitely positive. Good rapport with the dentist, interest in the dental procedures, laughter and enjoyment

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Standard preventive advice+ enzymatic mouth sprays ( Oral7 mouth spray)
The following are advice that will be given face-to-face to parent and participant and a take home pamphlet would be provided: Ensure thorough cleaning especially at the gum line and in the areas between the teeth. To not share toothbrushes. To use toothpaste containing fluoride at least 1000ppm fluoride concentration. To store toothbrushes apart to prevent spread of diseases through the bristles. To brush teeth at least twice a day, after meals and before bed. To brush for as long as two to three minutes. Parents would be advised told to supervise the participant's brushing. Frequency of using the Mouth spray would be two puffs, three times a day that is in the morning after waking up, during tea time and before sleep. A squirt is to be applied to the right/left side of the mouth on the buccal aspect and a squirt on the lingual aspect. Parents will be asked to apply the spray and to supervise children during oral hygiene procedures.
Standard Preventive Advice + placebo mouth spray ( normal saline mouth spray )
The following are advice that will be given face-to-face to parent and participant and a take home pamphlet would be provided: Ensure thorough cleaning especially at the gum line and in the areas between the teeth. To not share toothbrushes. To use toothpaste containing fluoride at least 1000ppm fluoride concentration. To store toothbrushes apart to prevent spread of diseases through the bristles. To brush teeth at least twice a day, after meals and before bed. To brush for as long as two to three minutes. Parents would be advised told to supervise the participant's brushing. Frequency of using the mouth spray would be two puffs, three times a day that is in the morning after waking up, during tea time and before sleep. A squirt is to be applied to the right/left side of the mouth on the buccal aspect and a squirt on the lingual aspect. Parents will be asked to apply the spray and to supervise children during oral hygiene procedures.

Locations

Country Name City State
Malaysia Hospital Universiti Sains Malaysia Kubang Kerian Kelantan

Sponsors (1)

Lead Sponsor Collaborator
Hospital Universiti Sains Malaysia

Country where clinical trial is conducted

Malaysia, 

Outcome

Type Measure Description Time frame Safety issue
Other Saliva Bacterial Count The saliva sample would be collected from 3 patients each of both case control and study groups before and after the intervention. Saliva samples will be collected at the start of the study that is during the delivery of the short dental hygiene educational message, and after 4 weeks. On the day of the saliva sampling, each child will be prohibited from brushing their teeth in the morning and from eating or drinking anything (except water) for at least 2 hours before the saliva sampling time. Every sample will be aspirated by syringe to obtain 1-2 ml as total volume and the saliva sample will be placed in a tube containing the carrier solution. 4 weeks
Primary Plaque Score would be measured using the Silness-Loe Plaque Index 1964 from each patient before and after the intervention in both control and case study groups and the mean score and standard deviation would be recorded in a table.
Scoring Criteria 0 No plaque
A film of plaque adhering to the free gingival margin and adjacent area of the tooth.
Moderate accumulation of deposits within the gingival pocket, on the gingival margin and/ or adjacent tooth surface.
Abundance of soft matter within the gingival pocket and/or on the tooth and gingival margin.
PIaque Score formula:
Total scores / No of teeth examined
Range of scores :
Excellent : 0 Good : 0.1-0.9 Fair: 1.0-1.9 Poor: 2.0-3.0
4 weeks
Secondary Gingivitis Score would be measured using the Loe and Silness Gingival Index 1963 from each patient before and after the intervention in both control and case study groups and the mean score and standard deviation would be recorded in a table.
Scoring Criteria 0 No inflammation.
Mild inflammation, slight change in color, slight edema, no bleeding on probing.
Moderate inflammation, moderate glazing, redness, bleeding on probing.
Severe inflammation, marked redness and hypertrophy, ulceration, tendency to spontaneous bleeding.
Gingivitis score for the individual would be calculated using a formula as follows :
Sum of indices of teeth / no of teeth examined
These scores would be then classified into either a Mild , Moderate or Severe form of Gingivitis as follows :
Mild gingivitis : 0.1-1.0 Moderate gingivitis : 1.1-2.0 Severe gingivitis : 2.1-3.0
4 weeks
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05568290 - Interleukin-38 Levels in Individuals With Periodontitis
Completed NCT04402996 - Meteorin-like Levels in Individuals With Periodontitis
Not yet recruiting NCT06016023 - Evaluation of Macrophage Inflammatory Protein-1α as a Periodontal Disease Biomarker
Not yet recruiting NCT05497895 - The Assessment of Clinical Efficacy of Topical Application of 5% Thymoquinone Gel for Gingivitis Patients Early Phase 1
Completed NCT02884817 - Essential Oil+ELA, Plaque and Gingivitis Phase 4
Completed NCT02633345 - Effects on Tablets Containing Probiotic Candidate Strains N/A
Completed NCT02552589 - Effect of Toothpaste on the Reduction of Plaque and Inflammation N/A
Completed NCT02235532 - Effects of Aloe Vera Toothpaste on Periodontal Parameters N/A
Completed NCT02980497 - Antiplaque/Antigingivitis Efficacy of Essential Oil Mouthrinses in Six-Month Study N/A
Completed NCT02515929 - Prospective Double-Blind Randomized Controlled Clinical Trial in the Gingivitis Prevention With OPCs Phase 4
Unknown status NCT01956656 - Efficacy Of Lotus Leaves In Management Of Plaque Induced Gingivitis N/A
Completed NCT01941797 - Experimental Peri-implant Mucositis in Humans N/A
Completed NCT02508987 - Obesity and Oxidative Stress in Patients With Different Periodontal Status N/A
Completed NCT01593540 - Clinical Examination of Metal Free Interdental Brushes Phase 4
Unknown status NCT01197105 - Evaluation Study of a Mouthwash Based on Schinus Terebinthifolius to Treat Gingivitis in Children Phase 1/Phase 2
Completed NCT01236963 - Essential Oils Mouth Rinse and Dental Floss: Efficacy on Interproximal Gingivitis and Dental Plaque Accumulation N/A
Completed NCT02102295 - Effects of Antioxidant Dentifrice on Gingivitis Phase 3
Completed NCT06140784 - A Clinical Study to Assess the Gingivitis and Plaque Effects of Various Dentifrices N/A
Completed NCT02937636 - To Investigate the Gingivitis Efficacy of a Stannous Fluoride Dentifrice in a Chinese Population N/A
Completed NCT06212908 - Assessment of Periodontal Therapy and Biofilm Management in Breast Cancer N/A